Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.601, 2010-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
First-line erlotinib maintenance cost effective in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 633, 2011-01 ,pp. :
Access to resources
Recommend
Gemcitabine alone or in combination with cisplatin cost effective in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 363, 2002-01 ,pp. :
Erlotinib dominates docetaxel for NSCLC
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :
Erlotinib improves QOL in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :
Erlotinib dominates docetaxel for NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. :